General information on the use of medical cannabis for professionals:
Treatment recommendations from/for the practice
SSCM is currently working on therapy recommendations, whereby the following topics will soon be available: MS-related spasticity, fibromyalgia, dementia, tourette- and restless legs syndrome. Further recommendations are planned, such as for pain, oncology/palliative care, psychiatry, epilepsy and movement disorders.
Please contact firstname.lastname@example.org if you have an appropriate expertise or clinical experience and are interested in a cooperation. We would appreciate any active collaborative efforts.
See website DE
General dosing recommendations: ↓ PDF (in prep.)
General side effects, contraindications, interactions: ↓ PDF (in prep.)
Overview of cannabis- and cannabinoid-based pharmaceutical preparations marketed in Switzerland; galenics, dosages, effects, indications, manufacturers, costs:
Guidelines Forum Suchtmedizin Ostschweiz, Fosumos